USPTO serial 79298102
RADICAVA ORS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- SOBRAL, CHRISTINA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RADICAVA ORS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
JP
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey L. Costellia
Jeffrey L. Costellia Nixon Peabody LLP799 9th Street, NW, Suite 500Washington, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); pharmaceutical preparations for the treatment of acute ischemic stroke | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks owned by K.K. BCJ-94
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks in Class 005
- Similar marks named RADICAVA ORS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 1, 2026 | DCPN | CHANGE OF OWNER RECEIVED FROM IB | — |
| Dec 6, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 17, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 17, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 14, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |